PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,906,226 | -20.4% | 2,023,836 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $26,278,628 | -9.4% | 2,004,472 | -22.8% | 0.00% | 0.0% |
| Q1 2023 | $29,012,245 | +42.2% | 2,595,013 | +7.2% | 0.00% | 0.0% |
| Q4 2022 | $20,397,397 | -61.2% | 2,419,620 | -23.2% | 0.00% | -50.0% |
| Q3 2022 | $52,509,000 | +13.8% | 3,151,742 | +0.6% | 0.00% | +100.0% |
| Q2 2022 | $46,124,000 | -28.9% | 3,133,510 | +19.8% | 0.00% | -50.0% |
| Q1 2022 | $64,916,000 | -19.8% | 2,616,519 | +3.6% | 0.00% | 0.0% |
| Q4 2021 | $80,961,000 | -8.2% | 2,524,488 | +3.0% | 0.00% | 0.0% |
| Q3 2021 | $88,227,000 | +5.9% | 2,452,115 | +29.9% | 0.00% | 0.0% |
| Q2 2021 | $83,311,000 | +59.5% | 1,888,275 | +65.4% | 0.00% | +100.0% |
| Q1 2021 | $52,219,000 | -31.1% | 1,141,640 | +3.9% | 0.00% | -50.0% |
| Q4 2020 | $75,836,000 | – | 1,098,759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |